Skip to main content
Kevin J. Whitehead
( out of 87 reviews )

Kevin J. Whitehead, MD

Languages spoken: Norwegian, English, French

Clinical Locations

Primary Location

University of Utah Hospital

Utah Adult Congential Heart Clinic
50 N Medical Dr
Salt Lake City , UT 84132

Saint Alphonsus Regional Medical Center

1055 N. Curtis Road
Boise , ID 83706

HHT Center

HHT Center
50 N Medical Dr
Salt Lake City , UT 84132

Primary Children's Hospital

100 N Mario Capecchi Drive
Salt Lake City , UT 84113

Dr. Kevin Whitehead is an Associate Professor of Cardiovascular Medicine at the University of Utah, and Adjunct Associate Professor of Pediatric Cardiology at Primary Children's Medical Center. He also is an Attending Physician at the George E. Wahlen Veterans Affairs Medical Center. He is co-director of the Utah Adult Congenital Heart Disease Program and is board certified in Internal Medicine, Cardiovascular Disease, Adult Congenital Heart Disease and Comprehensive Echocardiography. He cares for adults with congenital heart disease, heart disease in pregnancy, and other patients with cardiac complications of genetic diseases (such as muscular dystrophies). As an outgrowth of his interests in congenital and genetic cardiovascular diseases, Dr. Whitehead is also the Director of the Utah Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence, and in this role provides overall medical management and coordination of care to HHT patients seen at the University.

Dr. Whitehead received his M.D. from the University of Alberta, and did an Internal Medicine residency at the University of Western Ontario. He completed Cardiology fellowship and a Cardiovascular Research fellowship at the University of Utah, where he was named a Pfizer Cardiovascular Research Fellow in 2000. He is a fellow of the American Heart Association, and a member of the American Society of Echocardiography and the North American Vascular Biology Organization.

Board Certification

Fellow of Royal College of Physicians of Canada

Patient Rating

4.9 /5
( out of 87 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

UNIVERSITY HOSPITAL

Thoroughly explained what he felt would be important for me to stay healthy. Appreciate the time he took for this.

UNIVERSITY HOSPITAL

Dr. Whitehead is amazing with his knowledge and TIME with HHT! with all it's complexity's. He listens and provides answers when he can & if he doesn't know the answer is great at finding out one. I appreciate his service as one of a team of Docs I have. He being the leader for other docs as well to explain things when needed! Thank you Dr. Whitehead!

UNIVERSITY HOSPITAL

Dr. Whitehead and the staff in the Cardiology department are excellent.

UNIVERSITY HOSPITAL

Amazing HHT healthcare Doctor

EXTERNAL SITE

Excellent in all respects!

UNIVERSITY HOSPITAL

Dr. Whitehead is a rarity in the medical profession

UNIVERSITY HOSPITAL

Dr Whitehead is one of the most caring physicians that has ever treated me. He answered all of my questions in a way that I could understand. He took all the time I needed to understand my medical issues. I have never met such an informative medical professional.

UNIVERSITY HOSPITAL

I have never met a physician who was more interested in my medical problems. He spent a great deal of time listening and explaining the details of my education condition which is HHT. I have been to several Erica institutions around the country but have NEVER had anyone show the interest in my history or present situation as Dr Whithead did. His entire staff was very knowledgeable about HHT and interested in my experiences. I really cant say enough about the fabulous care I had.

UNIVERSITY HOSPITAL

I appreciate how Dr. Whitehead listens and helps me understand my heart health, my needs, and what plans there are to take care of me now and in the future.

Dr. Kevin Whitehead is an Associate Professor of Cardiovascular Medicine at the University of Utah, and Adjunct Associate Professor of Pediatric Cardiology at Primary Children's Medical Center. He also is an Attending Physician at the George E. Wahlen Veterans Affairs Medical Center. He is co-director of the Utah Adult Congenital Heart Disease Program and is board certified in Internal Medicine, Cardiovascular Disease, Adult Congenital Heart Disease and Comprehensive Echocardiography. He cares for adults with congenital heart disease, heart disease in pregnancy, and other patients with cardiac complications of genetic diseases (such as muscular dystrophies). As an outgrowth of his interests in congenital and genetic cardiovascular diseases, Dr. Whitehead is also the Director of the Utah Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence, and in this role provides overall medical management and coordination of care to HHT patients seen at the University.

Dr. Whitehead received his M.D. from the University of Alberta, and did an Internal Medicine residency at the University of Western Ontario. He completed Cardiology fellowship and a Cardiovascular Research fellowship at the University of Utah, where he was named a Pfizer Cardiovascular Research Fellow in 2000. He is a fellow of the American Heart Association, and a member of the American Society of Echocardiography and the North American Vascular Biology Organization.

Board Certification and Academic Information

Academic Departments Internal Medicine -Associate Professor
Pediatrics -Adjunct Associate Professor
Academic Divisions Cardiovascular Medicine
Cardiology
Board Certification
Fellow of Royal College of Physicians of Canada

Education history

Undergraduate Pre-Medicine - University of Lethbridge
Undergraduate Biochemistry - University of Lethbridge
Undergraduate Medical Science - University of Alberta B.Med.Sci.
Professional Medical Medicine - University of Alberta - School of Medicine M.D.
Internship Internal Medicine - University of Western Ontario Intern
Residency Internal Medicine - University of Western Ontario Resident
Fellowship Cardiology - University of Utah School of Medicine Fellow

Selected Publications

Journal Article

  1. Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, Deslandres E, Kasthuri RS, Lausman A, Poetker D, Ratjen F, Chesnutt MS, Clancy M, Whitehead KJ, Al-Samkari H, Chakinala M, Conrad M, Cortes D, Crocione C, Darling J, de Gussem E, Derksen C, Dupuis-Girod S, Foy P, Geisthoff U, Gossage JR, Hammill A, Heimdal K, Henderson K, Iyer VN, Kjeldsen AD, Komiyama M, Korenblatt K, McDonald J, McMahon J, McWilliams J, Meek ME, Mei-Zahav M, Olitsky S, Palmer S, Pantalone R, Piccirillo JF, Plahn B, Porteous MEM, Post MC, Radovanovic I, Rochon PJ, Rodriguez-Lopez J, Sabba C, Serra M, Shovlin C, Sprecher D, White AJ, Winship I, Zarrabeitia R (2020). Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med, 173(12), 989-1001.
  2. Mleynek TM, Chan AC, Redd M, Gibson CC, Davis CT, Shi DS, Chen T, Carter KL, Ling J, Blanco R, Gerhardt H, Whitehead K, Li D (2014). Lack of CCM1 induces hypersprouting and impairs response to flow. Human molecular genetics, 23(23), 6223-34.
  3. Hart BL, Mabray MC, Morrison L, Whitehead KJ, Kim (2021). Systemic and CNS manifestations of inherited cerebrovascular malformations. Clinical imaging, 75, 55-66.
  4. Girard R, Zeineddine HA, Koskimäki J, Fam MD, Cao Y, Shi C, Moore T, Lightle R, Stadnik A, Chaudagar K, Polster S, Shenkar R, Duggan R, Leclerc D, Whitehead KJ, Li DY, Awad I (2018). Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circulation research, 122(12), 1716-1721.
  5. Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, Walker AE, Goitre L, Delle Monache S, Retta SF, Shiu YT, Grossmann AH, Thomas KR, Donato AJ, Lesniewski LA, Whitehead KJ, Li D (2015). Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation, 131(3), 289-99.
  6. Gonzalez CD, Cipriano SD, Topham CA, Stevenson DA, Whitehead KJ, Vanderhooft S, Presson AP, McDonald (2019). Localization and age distribution of telangiectases in children and adolescents with hereditary hemorrhagic telangiectasia: A retrospective cohort study. Journal of the American Academy of Dermatology, 81(4), 950-955.
  7. Wooderchak-Donahue WL, McDonald J, Farrell A, Akay G, Velinder M, Johnson P, VanSant-Webb C, Margraf R, Briggs E, Whitehead KJ, Thomson J, Lin AE, Pyeritz RE, Marth G, Bayrak-Toydemir (2018). Genome sequencing reveals a deep intronic splicing ACVRL1 mutation hotspot in Hereditary Haemorrhagic Telangiectasia. Journal of medical genetics, 55(12), 824-830.
  8. Whitehead KJ, Sautter NB, McWilliams JP, Chakinala MM, Merlo CA, Johnson MH, James M, Everett EM, Clancy MS, Faughnan ME, Oh SP, Olitsky SE, Pyeritz RE, Gossage J (2016). Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. JAMA, 316(9), 943-51.
  9. Balakrishnan B, Verheijen J, Lupo A, Raymond K, Turgeon C, Yang Y, Carter KL, Whitehead KJ, Kozicz T, Morava E, Lai (2019). A novel phosphoglucomutase-deficient mouse model reveals aberrant glycosylation and early embryonic lethality. Journal of inherited metabolic disease, 42(5), 998-1007.
  10. Hunter BN, Timmins BH, McDonald J, Whitehead KJ, Ward PD, Wilson K (2016). An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2. The Laryngoscope, 126(4), 786-90.
  11. Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, Flemming KD, Girard R, Hobson N, Koenig JI, Koskimäki J, Lane K, Liao JK, Lee C, Lyne SB, McBee N, Morrison L, Piedad K, Shenkar R, Sorrentino M, Thompson RE, Whitehead KJ, Zeineddine HA, Hanley DF, Awad I (2019). Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery, 85(6), 843-853.
  12. Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B, Kim H, Jusue-Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead (2017). Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery, 80(5), 665-680.
  13. Flemming KD, Kumar S, Brown RD Jr, Singh RJ, Whitehead K, McCreath L, Lanzino (2020). Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level. Cerebrovascular diseases (Basel, Switzerland), 49(2), 216-222.
  14. Andrade L, Hoskoppal A, Hunt Martin M, Whitehead K, Ou Z, Kuang J, Cox (2021). Intracranial aneurysm and coarctation of the aorta: prevalence in the current era. Cardiology in the young, 31(2), 229-232.
  15. Shanmugam G, Wang D, Gounder SS, Fernandes J, Litovsky SH, Whitehead K, Radhakrishnan RK, Franklin S, Hoidal JR, Kensler TW, Dell'Italia L, Darley-Usmar V, Abel ED, Jones DP, Ping P, Rajasekaran N (2020). Reductive Stress Causes Pathological Cardiac Remodeling and Diastolic Dysfunction. Antioxidants & redox signaling, 32(18), 1293-1312.
  16. Wooderchak-Donahue WL, Akay G, Whitehead K, Briggs E, Stevenson DA, O'Fallon B, Velinder M, Farrell A, Shen W, Bedoukian E, Skrabann CM, Antaya RJ, Henderson K, Pollak J, Treat J, Day R, Jacher JE, Hannibal M, Bontempo K, Marth G, Bayrak-Toydemir P, McDonald (2019). Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?. Genetics in medicine, 21(9), 2007-2014.
  17. McDonald J, Bayrak-Toydemir P, DeMille D, Wooderchak-Donahue W, Whitehead (2020). Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2). Genetics in medicine, 22(7), 1201-1205.
  18. Weber LM, McDonald J, Whitehead (2018). Vitamin D levels are associated with epistaxis severity and bleeding duration in hereditary hemorrhagic telangiectasia. Biomarkers in medicine, 12(4), 365-371.
  19. Tang AT, Sullivan KR, Hong CC, Goddard LM, Mahadevan A, Ren A, Pardo H, Peiper A, Griffin E, Tanes C, Mattei LM, Yang J, Li L, Mericko-Ishizuka P, Shen L, Hobson N, Girard R, Lightle R, Moore T, Shenkar R, Polster SP, Roedel CJ, Li N, Zhu Q, Whitehead KJ, Zheng X, Akers A, Morrison L, Kim H, Bittinger K, Lengner CJ, Schwaninger M, Velcich A, Augenlicht L, Abdelilah-Seyfried S, Min W, Marchuk DA, Awad IA, Kahn M (2019). Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. Science translational medicine, 11(520),
  20. Girard R, Zeineddine HA, Fam MD, Mayampurath A, Cao Y, Shi C, Shenkar R, Polster SP, Jesselson M, Duggan R, Mikati AG, Christoforidis G, Andrade J, Whitehead KJ, Li DY, Awad I (2018). Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Translational stroke research, 9(1), 34-43.
  21. McDonald J, Wooderchak-Donahue W, VanSant Webb C, Whitehead K, Stevenson DA, Bayrak-Toydemir (2015). Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Frontiers in genetics, 6, 1.
  22. Kilian A, Latino GA, White AJ, Clark D, Chakinala MM, Ratjen F, McDonald J, Whitehead K, Gossage JR, Lin D, Henderson K, Pollak J, McWilliams JP, Kim H, Lawton MT, Faughnan ME, the Brain Vascular Malformation Consortium HHT Investigator Group (2020). Genotype-Phenotype Correlations in Children with HHT. Journal of clinical medicine, 9(9),
  23. Lyne SB, Girard R, Koskimäki J, Zeineddine HA, Zhang D, Cao Y, Li Y, Stadnik A, Moore T, Lightle R, Shi C, Shenkar R, Carrión-Penagos J, Polster SP, Romanos S, Akers A, Lopez-Ramirez M, Whitehead KJ, Kahn ML, Ginsberg MH, Marchuk DA, Awad I (2019). Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI insight, 4(12),
  24. Thomson RS, Molin NL, Whitehead KJ, Ashby S, Johnson L, Ward PD, McRae BR, Wilson KF, McDonald (2018). The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia. Laryngoscope investigative otolaryngology, 3(3), 178-181.
  25. Son SL, Hosek LL, Stein MC, Allshouse AA, Catino AB, Hoskoppal AK, Cox DA, Whitehead KJ, Lindsay IM, Esplin S, Metz T (2022). Association between pregnancy and long-term cardiac outcomes in individuals with congenital heart disease. American journal of obstetrics and gynecology, 226(1), 124.e1-124.e8.
  26. Cho JM, Park SK, Ghosh R, Ly K, Ramous C, Thompson L, Hansen M, Mattera MSLC, Pires KM, Ferhat M, Mookherjee S, Whitehead KJ, Carter K, Buffolo M, Boudina S, Symons J (2021). Late-in-life treadmill training rejuvenates autophagy, protein aggregate clearance, and function in mouse hearts. Aging cell, 20(10), e13467.
  27. Shankar TS, Ramadurai DKA, Steinhorst K, Sommakia S, Badolia R, Thodou Krokidi A, Calder D, Navankasattusas S, Sander P, Kwon OS, Aravamudhan A, Ling J, Dendorfer A, Xie C, Kwon O, Cheng EHY, Whitehead KJ, Gudermann T, Richardson RS, Sachse FB, Schredelseker J, Spitzer KW, Chaudhuri D, Drakos S (2021). Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis. Nature communications, 12(1), 4583.
  28. Sun B, Rouzbehani OMT, Kramer RJ, Ghosh R, Perelli RM, Atkins S, Fatahian AN, Davis K, Szulik MW, Goodman MA, Hathaway MA, Chi E, Word TA, Tunuguntla H, Denfield SW, Wehrens XHT, Whitehead KJ, Abdelnasser HY, Warren JS, Wu M, Franklin S, Boudina S, Landstrom A (2023). Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-ß Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice. Circulation. Heart failure, 16(12), e010351.
  29. Kilian A, Latino GA, White AJ, Ratjen F, McDonald J, Whitehead KJ, Gossage JR, Krings T, Lawton MT, Kim H, Faughnan ME, The Brain Vascular Malformation Consortium Hht Investigator Grou (2023). Reply to Eker et al. Comment on "Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704". Journal of clinical medicine, 12(23),
  30. McDonald J, Kornish J, Stevenson DA, Hanson-Kahn A, Balch H, James J, Naik H, Whitehead K (2023). Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited. Genetics in medicine, 25(8), 100865.
  31. Whitehead KJ,Toydemir D,Wooderchak-Donahue W,Oakley GM,McRae B,Putnam A,McDonald J,Bayrak-Toydemir (2024). Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT). International journal of molecular sciences, 25(14),
  32. Beslow LA,Krings T,Kim H,Hetts SW,Lawton MT,Ratjen F,Whitehead KJ,Gossage JR,McCulloch CE,Clancy M,Bagheri N,Faughnan ME,Faughnan ME,Chakinala MM,Clancy M,Hammill AM,Henderson K,Hetts SW,Hountras P,Iyer V,Kasthuri RS,Lin D,Mager JJ,Marchuk DA,McWilliams JP,McDonald J,Pawlikowska L,Pollak J,Swanson K,Vethanayagam D,Weinsheimer S,White AJ,Wilcox (2024). De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Pediatric neurology, 155, 120-125.
  33. Beslow LA,Vossough A,Kim H,Nelson J,Lawton MT,Pollak J,Lin DDM,Ratjen F,Hammill AM,Hetts SW,Gossage JR,Whitehead KJ,Faughnan ME,Krings T,Atherton ME,Chakinala MM,Clancy MS,Henderson K,Hetts SW,Hountras P,Iyer V,Kasthuri RS,Lin D,Mager JJ,Marchuk DA,McWilliams JP,McDonald J,Pawlikowska L,Swanson K,Vethanayagam D,Weinsheimer S,White AJ,Wilcox (2024). Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia. Child's nervous system, 40(7), 2101-2108.
  34. Landstrom AP,Spears T,D'Ottavio A,Chiswell K,Sommerhalter K,Soim A,Farr SL,Crume T,Book WM,Whitehead K,Botto LD,Li JS,Hsu D (2024). Cardiovascular disease risk factors in congenital heart disease survivors are associated with heart failure. Pediatric research,
  35. Kilian A,Latino GA,White AJ,Ratjen F,McDonald J,Whitehead KJ,Gossage JR,Krings T,Lawton MT,Kim H,Faughnan M (2023). Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. Journal of clinical medicine, 12(7),
  36. Kaufman CS,McDonald J,Balch H,Whitehead (2022). Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know. Seminars in interventional radiology, 39(3), 261-270.
  37. Kilian A,Latino GA,White AJ,Clark D,Chakinala MM,Ratjen F,McDonald J,Whitehead K,Gossage JR,Lin D,Henderson K,Pollak J,McWilliams JP,Kim H,Lawton MT,Faughnan ME,Chakinala M,Clancy MS,Gossage JR,Henderson K,Iyer V,Kasthuri RS,Kim H,Krings T,Lawton MT,Lin D,Mager JJ,Marchuk DA,McWilliams JP,McDonald J,Pawlikowska L,Pollak J,Ratjen F,Swanson K,Vethanayagam D,Wilcox (2020). Genotype'phenotype correlations in children with hht. Journal of clinical medicine, 9(9), 1-9.
  38. Thomson RS,Molin NL,Whitehead KJ,Ashby S,Johnson L,Ward PD,McRae BR,Wilson KF,McDonald (2018). The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia. Laryngoscope investigative otolaryngology, 3(3), 178-181.
  39. McDonald J,Wooderchak-Donahue W,VanSant Webb C,Whitehead K,Stevenson DA,Bayrak-Toydemir (2015). Hereditary hemorrhagic telangiectasia: Genetics and molecular diagnostics in a new era. Frontiers in genetics, 5(JAN),
  40. Gounder SS,Kannan S,Devadoss D,Miller CJ,Whitehead KS,Odelberg SJ,Firpo MA,Paine R,Hoidal JR,Abel ED,Rajasekaran N (2013). Correction: Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. PloS one, 8(6),
  41. Chan AC,Drakos SG,Ruiz OE,Smith ACH,Gibson CC,Ling J,Passi SF,Stratman AN,Sacharidou A,Revelo MP,Grossmann AH,Diakos NA,Davis GE,Metzstein MM,Whitehead KJ,Li D (2012). Erratum: Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice (Journal of Clinical Investigation (2011) 121, 5 (1871-1881) DOI: 10.1172/JCI44393). The Journal of clinical investigation, 122(5), 1948.
  42. Whitehead KJ,Chan AC,Navankasattusas S,Koh W,London NR,Ling J,Mayo AH,Drakos SG,Jones CA,Zhu W,Marchuk DA,Davis GE,Li D (2009). Erratum: The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases (Nature Medicine (2009) 15 (177-184)). Nature medicine, 15(4), 462.
  43. Al-Samkari H, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, Whitehead KJ, Conrad MB, Zumberg MS, Zhou JY, Parambil J, Marsh D, Clancy M, Bradley L, Wisniewski L, Carper BA, Thomas SM, McCrae K (2024). Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia. The New England journal of medicine, 391(11), 1015-1027.
  44. Steinberg BA, Tandar A, Whitehead K (2024). Helix-fixed leadless pacemaker implantation through a valve-in-valve tricuspid prosthesis via the femoral approach. Journal of interventional cardiac electrophysiology, 67(5), 915-917.
  45. Kilian A, Latino GA, White AJ, Ratjen F, McDonald J, Whitehead KJ, Gossage JR, Krings T, Lawton MT, Kim H, Faughnan ME, The Brain Vascular Malformation Consortium Hht Investigator Grou (2023). Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. Journal of clinical medicine, 12(7),
  46. Botto LD, Reeder MR, Lui GK, Glidewell MJ, Book WM, Crume TL, DeLaRosa JM, d'Ottavio A, Downing KF, Feldkamp ML, Hsu DT, Khanna AD, Krikov S, Pinto NM, Raskind Hood CL, Rodriguez FH 3rd, Soim AS, Whitehead KJ, Chiswell K, Li J (2025). Comorbidity and Multimorbidity in Adults With Congenital Heart Disease: Findings From a Multi-Site Population-Based Study. Birth defects research, 117(8), e2515.

Letter

  1. Kilian A,Latino GA,White AJ,Ratjen F,McDonald J,Whitehead KJ,Gossage JR,Krings T,Lawton MT,Kim H,Faughnan M (2023). Reply to Eker et al. Comment on ¿Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704¿. Journal of clinical medicine, 12(23),

Video/Film/CD/Web/Podcast

  1. Cure HH (2019). Dr Whitehead's Interview Highlighting Utah HHT Center.